BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9790114)

  • 1. Atrophic and plaquelike dermatofibrosarcoma protuberans.
    Davis DA; Sánchez RL
    Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature.
    Sheehan DJ; Madkan V; Strickling WA; Peterson CM
    Cutis; 2004 Oct; 74(4):237-42. PubMed ID: 15551716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Arican O; Bakaris S; Bulbuloglu E; Ezberci F
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
    Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
    Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic dermatofibrosarcoma protuberans with diffuse eosinophilic infiltrate.
    Hirashima N; Misago N; Shinogi T; Inoue T; Miura Y; Narisawa Y
    J Dermatol; 2006 Jul; 33(7):486-8. PubMed ID: 16848822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma Protuberans Presenting as a Large Atrophic Plaque on the Chest.
    Saigusa R; Miyagawa T; Toyama S; Omatsu J; Miyagaki T; Masui Y; Yamada D; Sato S
    Acta Derm Venereol; 2018 Jan; 98(1):155-156. PubMed ID: 28929166
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
    Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
    Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
    Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
    Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing dermatofibrosarcoma protuberans.
    Diaz-Cascajo C; Weyers W; Borghi S
    J Cutan Pathol; 1998 Sep; 25(8):440-4. PubMed ID: 9826170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
    Harvell JD; Kilpatrick SE; White WL
    Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34 expression in desmoplastic melanoma.
    Hoang MP; Selim MA; Bentley RC; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Nov; 28(10):508-12. PubMed ID: 11737519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.